Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YOR329W-A (YOR329W-A)

Shipped with Ice Packs
In Stock

Description

Introduction

YOR329W-A is a putative uncharacterized protein encoded by the YOR329W-A gene in Saccharomyces cerevisiae. Despite its classification as a "smORF" (small Open Reading Frame) or uncharacterized protein, recombinant production systems have enabled its study, though functional roles remain elusive. This article synthesizes available data on its structural features, recombinant production methods, and potential biological relevance.

Recombinant Production and Applications

YOR329W-A is commercially available as recombinant protein and polyclonal antibodies (anti-YOR329W-A) . Key applications include:

  • Antibody Production: Rabbit-derived polyclonal antibodies are used for ELISA and Western blotting .

  • Functional Studies: While no functional data exist, its recombinant form enables hypothesis-driven experiments (e.g., subcellular localization, interaction assays).

Table 1: Recombinant YOR329W-A Products

Product TypeHostPurityApplications
Recombinant ProteinE. coli/Yeast≥85% (SDS-PAGE)ELISA, Western blotting
Cell-Free Expression SystemIn vitro≥85% (SDS-PAGE)Structural studies
Polyclonal AntibodyRabbitAffinity-purifiedImmunodetection

Research Findings and Gaps

  • Expression Data: No expression profiles are available in S. cerevisiae, as indicated by the Saccharomyces Genome Database (SGD) .

  • Functional Hypotheses:

    • Vacuolar Role: Localization to the Vid complex suggests potential involvement in protein degradation or vacuolar membrane dynamics .

    • Retrotransposon Regulation: Indirectly linked to Ty1 retrotransposon studies, though no direct evidence exists .

Key Challenges:

  1. Limited Functional Data: No peer-reviewed studies on catalytic activity, interactions, or phenotypic effects.

  2. Ambiguous Classification: Designated as "uncharacterized" due to insufficient experimental validation.

Comparative Insights from Related Proteins

While YOR329W-A lacks direct homologs, its potential vacuolar localization parallels other S. cerevisiae proteins:

  • Proteinase A: A vacuolar aspartic protease essential for hydrolase activation .

  • NMN Adenylyltransferase (YLR328W): Catalyzes NAD synthesis, with structural and functional data established .

Future Directions

To elucidate YOR329W-A’s role, prioritize:

  1. High-Throughput Screening: Use CRISPR knockout/mutant libraries to identify phenotypic changes.

  2. Proteomic Interactomes: Co-IP/mass spectrometry to map interactions with vacuolar or retrotransposon-related proteins.

  3. Structural Studies: X-ray crystallography or cryo-EM to determine 3D structure and active sites.

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them during order placement. We will fulfill your request whenever possible.
Lead Time
Delivery time may vary based on the purchase method and location. Please consult your local distributor for specific delivery timelines.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-69
Protein Length
full length protein
Target Protein Sequence
MFRYHVKFIEPAMIYKILANEKMQIIWVLNSYFEFYLLFCPRFLMLTLFLIGATYFCFLI WRKKVSRNK

Q&A

What is YOR329W-A protein and why is it significant for research?

YOR329W-A is a putative uncharacterized protein from Saccharomyces cerevisiae (baker's yeast), a model organism extensively used in molecular and cellular biology research. This protein consists of 69 amino acids with the sequence: MFRYHVKFIEPAMIYKILANEKMQIIWVLNSYFEFYLLFCPRFLMLTLFLIGATYFCFLIWRKKVSRNK . The significance of studying this protein lies in the fact that S. cerevisiae was the first yeast to have its entire genome sequenced, making it an invaluable model for understanding eukaryotic cellular processes. Uncharacterized proteins like YOR329W-A represent knowledge gaps in our understanding of yeast biology, and characterizing them could reveal novel cellular mechanisms, pathways, or functions that may have implications for broader eukaryotic biology. Research on such proteins contributes to completing the functional annotation of the yeast genome and potentially unveils new biotechnological applications .

How does YOR329W-A relate to other characterized proteins in Saccharomyces cerevisiae?

While YOR329W-A remains uncharacterized, its study should be approached through comparative analysis with known proteins. Using bioinformatics tools for sequence alignment, domain prediction, and phylogenetic analysis can reveal potential functional relationships with characterized proteins. Current research suggests that putative proteins like YOR329W-A may be involved in stress responses, membrane functioning, or cell cycle regulation based on expression patterns during different growth phases of S. cerevisiae. Methodologically, researchers should employ multiple sequence alignment tools (such as BLAST and Clustal Omega) to identify conserved domains, followed by co-expression analysis to identify genes with similar expression patterns, which may indicate functional relationships or pathway involvement .

What expression systems are recommended for recombinant YOR329W-A protein production?

E. coli expression systems are commonly used for producing recombinant YOR329W-A protein, particularly with N-terminal His-tags to facilitate purification . For methodological implementation, researchers should:

  • Clone the YOR329W-A gene into a suitable expression vector (pET series vectors work well)

  • Transform into a compatible E. coli strain (BL21(DE3) is frequently effective)

  • Optimize expression conditions:

    • IPTG concentration: 0.1-1.0 mM

    • Induction temperature: 16-37°C (lower temperatures may improve solubility)

    • Induction duration: 4-18 hours

Alternative expression systems to consider include yeast-based systems (particularly S. cerevisiae itself or Pichia pastoris) when post-translational modifications might be important for functional studies. Each system requires specific optimization strategies focused on codon optimization, induction parameters, and purification approaches .

What storage and handling protocols maintain YOR329W-A protein stability?

Based on current research, optimal storage and handling protocols for YOR329W-A protein include:

Storage ParameterRecommended ConditionNotes
Temperature-20°C/-80°CAliquoting necessary for multiple use
Buffer CompositionTris/PBS-based buffer, 6% Trehalose, pH 8.0Maintains structural integrity
ReconstitutionDeionized sterile water (0.1-1.0 mg/mL)Add 5-50% glycerol (final concentration)
Handling CautionAvoid repeated freeze-thaw cyclesWorking aliquots can be stored at 4°C for up to one week

For long-term storage, adding glycerol to a final concentration of 50% before aliquoting and storing at -80°C is recommended. When working with the protein, centrifuge vials briefly before opening to ensure contents are at the bottom, and minimize exposure to room temperature to prevent degradation .

What are the basic characterization methods for confirming YOR329W-A protein identity?

To confirm the identity of recombinant YOR329W-A protein, researchers should implement a multi-method characterization approach:

  • SDS-PAGE analysis: Confirms protein size (expected ~7.7 kDa plus tag size) and purity (should exceed 90%)

  • Western blotting: Using anti-His antibodies to verify tagged protein expression

  • Mass spectrometry (MS):

    • MALDI-TOF for molecular weight confirmation

    • LC-MS/MS for peptide mapping and sequence verification

  • N-terminal sequencing: To confirm the correct starting sequence

  • Circular dichroism (CD): To assess secondary structure elements

These techniques collectively provide confirmation of protein identity, purity, and basic structural characteristics. For uncharacterized proteins like YOR329W-A, thorough characterization is particularly important before proceeding to functional studies. Documentation should include gel images, MS spectra, and sequence confirmation reports to ensure reproducibility .

How should experimental designs be structured to investigate YOR329W-A function?

Investigating the function of an uncharacterized protein like YOR329W-A requires a systematic experimental approach following principles of robust experimental design. Researchers should structure their investigations using the following methodological framework:

  • Define variables carefully:

    • Independent variables: Genetic modifications, environmental conditions, interacting partners

    • Dependent variables: Growth rates, gene expression patterns, metabolic outputs

    • Control variables: Wild-type strains, standard growth conditions

  • Design experimental treatments with incrementally increasing complexity:

    • Gene deletion/knockout studies using CRISPR-Cas9

    • Overexpression studies with inducible promoters

    • Domain mutation studies to assess structure-function relationships

    • Protein localization studies using fluorescent tags

  • Implement between-subjects design for strain comparisons and within-subjects design for time-course studies

  • Control for extraneous variables by standardizing:

    • Media composition and pH

    • Growth temperature and aeration

    • Cell density and growth phase

    • Genetic background of strains

  • Apply randomization and replication:

    • Minimum of 3 biological replicates

    • Multiple technical replicates per condition

    • Random assignment of samples to analytical runs

This structured approach ensures that causal relationships can be established between genetic/environmental manipulations and observed phenotypes, leading to reliable functional characterization of YOR329W-A .

What approaches can resolve contradictory functional data for YOR329W-A?

When facing contradictory functional data for YOR329W-A, researchers should implement a systematic resolution strategy:

  • Data validation and quality assessment:

    • Re-examine raw data and statistical analyses

    • Verify reagent and strain authenticity

    • Assess experimental conditions for hidden variables

  • Contextual analysis:

    • Investigate strain-specific effects (genetic background differences)

    • Examine environmental condition variations (media, temperature, growth phase)

    • Consider potential post-translational modifications affecting function

  • Integration of multiple methodologies:

    • Combine genetic approaches (knockouts, point mutations)

    • Apply orthogonal biochemical assays

    • Implement in vivo and in vitro studies in parallel

  • Computational modeling:

    • Use structural predictions to inform hypotheses

    • Apply systems biology approaches to place contradictions in pathway context

    • Model protein interactions under different conditions

  • Collaborative verification:

    • Engage independent laboratories for verification

    • Standardize protocols across research groups

    • Conduct blind studies to minimize bias

This systematic approach transforms contradictory data from a research obstacle into an opportunity for deeper insights into the contextual functioning of YOR329W-A. Document all reconciliation attempts in publications to advance methodological approaches in the field .

How can high-throughput screening be optimized for identifying YOR329W-A interaction partners?

Optimizing high-throughput screening for YOR329W-A interaction partners requires careful experimental design and methodological considerations:

  • Primary screening methods selection:

    • Yeast two-hybrid (Y2H) with YOR329W-A as both bait and prey

    • Affinity purification-mass spectrometry (AP-MS) using tagged YOR329W-A

    • Protein microarrays with purified YOR329W-A as probe

  • Experimental design optimizations:

    • Use structured factorial design to test multiple conditions

    • Include appropriate positive and negative controls

    • Implement counter-screening to eliminate false positives

  • Data analysis pipeline development:

    • Apply statistical filters (p-value < 0.05, fold change > 2.0)

    • Use visualization tools to identify interaction clusters

    • Implement machine learning algorithms to prioritize candidates

  • Validation strategy implementation:

    • Select diverse candidates representing different functional categories

    • Confirm interactions using orthogonal methods (co-immunoprecipitation, FRET)

    • Perform functional studies to establish biological relevance

Screening MethodAdvantagesLimitationsValidation Approach
Yeast Two-HybridIn vivo detection, scalableHigh false positive rateCo-IP, BiFC
AP-MSDetects complexes, quantitativeRequires optimal conditionsReciprocal pulldowns
Protein MicroarraysHigh-throughput, direct bindingIn vitro onlySPR, ITC
BioIDCaptures transient interactionsRequires in-cell expressionMicroscopy co-localization

This integrated approach maximizes the discovery potential while minimizing false positives, ultimately leading to a reliable interactome map for YOR329W-A .

What techniques are optimal for studying YOR329W-A subcellular localization?

Determining the subcellular localization of YOR329W-A requires a multi-technique approach to ensure accurate characterization:

  • Fluorescent protein fusion constructs:

    • C-terminal and N-terminal GFP/mCherry fusions should both be tested

    • Expression under native promoter is preferable to avoid artifacts

    • Control experiments with known localization markers must be included

    • Time-course imaging during different growth phases is recommended

  • Immunofluorescence microscopy:

    • Requires generation of specific antibodies or use of tag-specific antibodies

    • Fixation protocols should be optimized for yeast cells (4% paraformaldehyde)

    • Permeabilization conditions must preserve cellular structures

    • Co-staining with organelle markers provides confirmation

  • Subcellular fractionation:

    • Differential centrifugation followed by Western blotting

    • Density gradient separation for finer resolution

    • Multiple fraction markers should be used to confirm separation quality

  • Proximity-based labeling:

    • BioID or APEX2 fusions to identify proximal proteins

    • Helps confirm localization while also identifying interaction partners

The combination of these techniques provides stronger evidence than any single method, as each has specific strengths and limitations. Researchers should report any differences observed between methods and investigate potential causes of discrepancies, such as tag interference with localization signals or condition-dependent localization patterns .

How should genetic knockouts be designed to study YOR329W-A function?

Designing genetic knockouts for studying YOR329W-A function requires careful consideration of the genomic context and potential off-target effects:

  • Knockout strategy selection:

    • Complete ORF deletion via homologous recombination

    • CRISPR-Cas9 targeted disruption

    • Conditional systems for essential genes (if YOR329W-A proves essential)

  • Design considerations:

    • Verify absence of overlapping genes or regulatory elements

    • Check for potential effects on neighboring genes

    • Design specific primers for knockout confirmation

    • Include selectable markers that minimally affect cellular physiology

  • Validation requirements:

    • PCR verification of correct insertion/deletion

    • RT-qPCR confirmation of transcript absence

    • Western blotting (if antibodies available)

    • Whole genome sequencing to check for off-target effects

  • Control strain creation:

    • Generate marker-only integration controls

    • Create complementation strains with wild-type YOR329W-A

    • Develop point mutant libraries for structure-function analysis

  • Phenotypic analysis matrix:

Condition CategorySpecific ConditionsMeasurementsControls
Growth conditionsVarious carbon sources, temperatures, pHGrowth rate, lag phase, yieldWild-type, marker control
Stress conditionsOxidative, osmotic, temperatureSurvival rate, stress gene expressionKnown stress-sensitive mutants
Cell cycleSynchronization, cell divisionCell size, budding index, cycle progressionEstablished cell cycle mutants
MetabolismFermentation, respirationMetabolite profiles, enzyme activitiesKnown metabolic mutants

This comprehensive approach ensures that the functional characterization of YOR329W-A through knockout studies is rigorous and accounts for potential confounding factors .

What are the best methods for analyzing post-translational modifications of YOR329W-A?

Post-translational modifications (PTMs) can significantly impact protein function, and analyzing them for YOR329W-A requires specialized methodologies:

  • Mass spectrometry-based approaches:

    • Enrichment strategies for specific PTMs (phosphopeptides, glycopeptides)

    • Multiple fragmentation techniques (CID, ETD, HCD) for comprehensive coverage

    • Quantitative analysis using SILAC or TMT labeling

    • Targeted MS methods (PRM, MRM) for specific site monitoring

  • Site-directed mutagenesis workflow:

    • In silico prediction of PTM sites using algorithms specific to each modification

    • Systematic mutation of predicted sites (Ser/Thr/Tyr to Ala for phosphorylation)

    • Functional analysis of mutants under relevant conditions

    • Rescue experiments with phosphomimetic mutations (Ser/Thr to Asp/Glu)

  • PTM-specific antibodies and staining:

    • Western blotting with modification-specific antibodies

    • Phos-tag SDS-PAGE for phosphorylation analysis

    • Pro-Q Diamond staining for phosphoprotein detection

    • Periodic acid-Schiff staining for glycosylation

  • Temporal dynamics analysis:

    • Time-course studies during different growth phases

    • Stress response time points

    • Cell cycle synchronization

For YOR329W-A specifically, researchers should focus on phosphorylation and acetylation analysis, as these modifications are common regulatory mechanisms in yeast proteins. The hydrophobic character of the protein sequence suggests that it may be membrane-associated, so lipid modifications should also be investigated .

How should researchers analyze global expression data to understand YOR329W-A function?

Analyzing global expression data to elucidate YOR329W-A function requires a systematic approach combining bioinformatics and experimental validation:

  • Experimental design for transcriptomics/proteomics:

    • Compare YOR329W-A knockout vs. wild-type under multiple conditions

    • Include time-course analysis during stress responses

    • Analyze YOR329W-A overexpression effects on global expression patterns

  • Primary data analysis pipeline:

    • Quality control and normalization of raw data

    • Differential expression analysis (DESeq2, limma)

    • Multiple testing correction (Benjamini-Hochberg FDR)

    • Fold change thresholds (typically ≥1.5-fold with p<0.05)

  • Secondary analysis for functional insights:

    • Gene Ontology (GO) enrichment analysis

    • Pathway analysis (KEGG, Reactome)

    • Transcription factor binding site analysis

    • Protein-protein interaction network construction

  • Integration of multiple omics datasets:

    • Correlation of transcriptome and proteome changes

    • Integration with metabolomics data

    • Cross-referencing with epigenomic data

  • Validation experiments:

    • RT-qPCR confirmation of key differentially expressed genes

    • ChIP assays to verify transcription factor associations

    • Reporter assays for pathway activation

This integrated approach allows researchers to move beyond simple lists of differentially expressed genes to develop testable hypotheses about YOR329W-A function in specific cellular processes or stress responses. The temporal and conditional aspects of gene expression changes are particularly informative for uncharacterized proteins .

What statistical approaches are most appropriate for analyzing YOR329W-A functional data?

  • Experimental design considerations for statistical robustness:

    • Power analysis to determine sample size (typically n≥3 biological replicates)

    • Randomization and blocking to control for batch effects

    • Inclusion of appropriate controls for normalization

  • Statistical test selection based on data characteristics:

Data TypeAppropriate TestsAssumptionsAlternatives for Non-parametric Data
Continuous measures (growth rate)t-test, ANOVA, linear regressionNormality, homoscedasticityMann-Whitney U, Kruskal-Wallis
Categorical outcomes (survival)Chi-square, Fisher's exactIndependent observationsN/A
Time-course dataRepeated measures ANOVA, mixed modelsSphericity, compound symmetryGeneralized estimating equations
High-dimensional dataFalse discovery rate correctionIndependence of testsPermutation testing
  • Advanced analytical approaches:

    • Principal Component Analysis (PCA) for dimensionality reduction

    • Hierarchical clustering for pattern identification

    • Machine learning for predictive modeling (Random Forest, SVM)

    • Bayesian approaches for incorporating prior knowledge

  • Visualization strategies:

    • Box plots with individual data points for transparency

    • Volcano plots for highlighting significant changes

    • Heatmaps for multivariate pattern visualization

    • Network graphs for interaction data

  • Reporting requirements:

    • Clear description of statistical methods used

    • Explicit statement of hypotheses tested

    • Comprehensive reporting of all statistical parameters

    • Availability of raw data and analysis code

How can researchers integrate structural predictions with functional data for YOR329W-A?

Integrating structural predictions with functional data provides deeper insights into YOR329W-A's biological role:

  • Structural prediction methodology:

    • Sequence-based secondary structure prediction (PSIPRED, JPred)

    • Homology modeling if templates exist (SWISS-MODEL, Phyre2)

    • Ab initio modeling for novel folds (Rosetta, AlphaFold)

    • Membrane topology prediction (TMHMM, Phobius)

  • Functional domain analysis:

    • Conserved domain searches (CDD, Pfam)

    • Motif identification (ELM, ScanProsite)

    • Binding site prediction (3DLigandSite, COACH)

    • Molecular dynamics simulations for flexibility analysis

  • Structure-function relationship analysis:

    • Map mutations to structural models

    • Correlate conservation patterns with structural features

    • Predict functional residues based on structural context

    • Design targeted mutations based on structural insights

  • Experimental validation of structural predictions:

    • Circular dichroism to verify secondary structure content

    • Limited proteolysis to identify domain boundaries

    • Site-directed mutagenesis of predicted functional residues

    • Crosslinking studies to validate interaction interfaces

  • Integrative modeling workflow:

    • Begin with sequence-based predictions

    • Refine models using experimental constraints

    • Iteratively improve models as new data becomes available

    • Document confidence levels for different regions of the model

Based on the available sequence data, YOR329W-A appears to have hydrophobic regions that may indicate membrane association or protein-protein interaction domains. Researchers should systematically test the functional significance of these features through targeted mutations and localization studies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.